Advisors Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Sell
82,327
-150,724
-65% -$1.8M 0.02% 782
2026
Q1
$1.4M Sell
233,051
-155,468
-40% -$1.17M 0.02% 706
2025
Q4
$2.79M Sell
388,519
-131,277
-25% -$1.04M 0.05% 498
2025
Q3
$5.55M Sell
519,796
-99,908
-16% -$980K 0.09% 293
2025
Q2
$6M Sell
619,704
-64,625
-9% -$667K 0.11% 248
2025
Q1
$10.2M Sell
684,329
-22,100
-3% -$340K 0.19% 117
2024
Q4
$10.5M Buy
706,429
+45,865
+7% +$747K 0.19% 110
2024
Q3
$12.6M Buy
660,564
+19,658
+3% +$407K 0.23% 85
2024
Q2
$13.3M Buy
640,906
+27,294
+4% +$542K 0.26% 65
2024
Q1
$11.5M Buy
613,612
+69,687
+13% +$1.2M 0.22% 93
2023
Q4
$7.84M Buy
543,925
+87,510
+19% +$1.19M 0.16% 145
2023
Q3
$7.92M Buy
456,415
+108,853
+31% +$2.27M 0.17% 131
2023
Q2
$7.23M Buy
347,562
+105,721
+44% +$2.3M 0.15% 152
2023
Q1
$5.69M Buy
241,841
+95,754
+66% +$2.57M 0.11% 201
2022
Q4
$4.08M Buy
146,087
+83,016
+132% +$2.12M 0.08% 283
2022
Q3
$1.48M Buy
63,071
+47,355
+301% +$1.43M 0.03% 591
2022
Q2
$530K Sell
15,716
-12,410
-44% -$435K 0.01% 928
2022
Q1
$982K Sell
28,126
-12,787
-31% -$437K 0.02% 806
2021
Q4
$1.25M Sell
40,913
-7,823
-16% -$255K 0.02% 771
2021
Q3
$1.6M Sell
48,736
-2,471
-5% -$79.1K 0.02% 663
2021
Q2
$1.55M Buy
+51,207
New +$1.69M 0.02% 682

Other funds holding OGN

Advisors Asset Management's OGN Position: Q2 2026 in Review

Advisors Asset Management reduced its Organon & Co (OGN) stake by 65% in Q2 2026, selling an estimated $1.8M and leaving 82,327 shares worth $1.11M. The position accounts for 0.02% of the portfolio, ranked #782.

Advisors Asset Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $13.3M in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Advisors Asset Management held 82,327 shares of Organon & Co worth $1.11M as of Q2 2026.
  • Advisors Asset Management sold 150,724 Organon & Co shares in Q2 2026, an estimated $1.8M.
  • Organon & Co made up 0.02% of Advisors Asset Management's portfolio in Q2 2026, its #782 holding.
  • Advisors Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Advisors Asset Management's Organon & Co position peaked at $13.3M in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.